Hypoglycemic episodes, moderate or severe, can effectively and efficiently be managed by nasal glucagon in adult patients with type 1 diabetes.
Mental health and behavioral screenings should be routine part of care for pediatric patients with diabetes
A new point-of-care C peptide test may increase ease and access to testing for patients with type 1 and type 2 diabetes.
In all groups of participants, a lower HbA1c was associated with a better health-related quality of life in type 1 diabetes.
A single session of HIIT can "rapidly reduce" awareness of hypoglycemia in patients with type 1 diabetes.
First look at research to be presented at ADA 2017.
Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.
There is a 5% probability of progression from state 1 to state 5 between retinal screenings.
Researchers examined whether within-day glycemic variability plays a role in microvascular complications.
Febuxostat was found to have a modest impact in lowering systolic blood pressure among patients with type 1 diabetes.
Patients with type 1 diabetes had higher mortality rates when admitted for acute myocardial infarction compared with patients with type 2 diabetes.
A randomized controlled trial assessed whether mild lower extremity compression can be safely used in patients with diabetes and concurrent lower extremity edema.
PLGM tied to smaller number of hypoglycemic events; increase in time spent 140 mg/dL
A study sought to determine if a virtual glucose management service can result in improved inpatient glycemic control.
Adjuvant metformin produced a small but nonsignificant decrease in body mass index and insulin dose, but by year 10, no beneficial effects were evident.
Black and Latino youth were less likely to undergo an eye examination for diabetic retinopathy within 6 years of their diagnosis.
The prevalence of complications associated with type 1 and type 2 diabetes diagnosed during childhood and adolescence was compared in a multicenter, observational study.
Age-adjusted diabetes incidence increased for every 1 degree celcius temperature increase.
A study found approximately one-third of people with diabetes were undiagnosed or unaware of the diagnosis.
An update to the ADA's 2017 Standards of Medical Care in Diabetes indicates that, barring contraindication, patients with type 2 diabetes should undergo metformin therapy as first-line treatment.
Insulin types and regimens should be determined on an individual basis since there is insufficient data to support one treatment over another.
Investigators found early signs of kidney disease, retinopathy, arterial stiffness, and hypertension in adolescents with either type 1 or type 2 diabetes.
Children younger than 12 were at an elevated risk of type 1 diabetes.
The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.
Exercise management for patients with type 1 diabetes should be individualized, depending on insulin concentrations and exercise type/intensity.
Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.
The use of hydrolyzed vs nonhydrolyzed cow's milk-based infant formula does not appear to reduce risk for islet autoimmunity.
People with type 1 diabetes have specific changes in gut bacteria and inflammation of the digestive tract compared with people without the disease.
A recent study confirms that frequent enterovirus infection may contribute to the development of type 1 diabetes in children.
The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.
Endocrinology Advisor Articles
- Maternal Deaths in the United States: Sounding a Call to Action
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain